Introduction: Due to the controversy surrounding diagnostic ultrasound evaluations and elective preterm delivery of fetuses with gastroschisis, we sought to calculate the predictive value of bowel dilation in fetuses with gastroschisis and evaluate the effect of preterm delivery on neonatal outcomes. Materials and Methods: Ultrasounds and medical records of 103 mother-infant pairs with fetal gastroschisis were reviewed. Eighty-nine pairs met the criteria. Intestinal complications, gestational age at delivery, birth weight, and number of abdominal surgeries were documented. Results: Forty-eight fetuses (54%) had bowel dilation and 41 (46%) did not. The positive predictive value of bowel dilation for complicated gastroschisis was 21%. There were 50 (56%) preterm and 39 (44%) term deliveries. The mean birth weight was 2,114 g (SD = 507) and 2,659 g (SD = 687), p = 0.001. For infants delivered preterm, the mean number of postnatal abdominal surgeries was 2.1 (SD = 1.1) as compared to 1.3 (SD = 0.5) surgical procedures for those infants delivered at term gestation. This was not statistically significant. With respect to hospital stay for each group, the mean length of neonatal intensive care unit admission was 48 days (SD = 33) in the preterm group and 35 days (SD = 50) in the term group, which was not statistically significant. Discussion: Ultrasound-detected bowel dilation was not predictive of important intestinal complications. Our data did not substantiate any benefit for elective preterm delivery of neonates with gastroschisis.

Keywords:
Bowel dilation, Gastroschisis, Ultrasound, Preterm delivery
1.
Wilson DR, Johnson MP: Congenital abdominal wall defects: an update. Fetal Diagn Ther 2004;19:385–398.
2.
Mastroiacovo P, Lisi A, Castilla EE: The incidence of gastroschisis: research urgently needs resources. Br Med J 2006;332:250–251.
3.
Huh NG, Hirose S, Goldstein RB: Prenatal intraabdominal bowel dilation is associated with postnatal gastrointestinal complications in fetuses with gastroschisis. Am J Obstet Gynecol 2010;202:396.e1–e6.
4.
Molik KA, Gingalewski CA, West KW, Rescorla FJ, Scherer LR, Engum SA, Grosfeld JL: Gastroschisis: a plea for risk categorization. J Pediatr Surg 2001;36:51–55.
5.
Babcook CJ, Hedrick MH, Goldstein RB, Callen PW, Harrison MR, Adzick NS, Filly RA: Gastroschisis: can sonography of the fetal bowel accurately predict postnatal outcome? J Ultrasound Med 1994;13:701–706.
6.
Piper HG, Jaksic T: The impact of prenatal bowel dilation on clinical outcomes in neonates with gastroschisis. J Pediatr Surg 2006;41:897–900.
7.
Jeejeebhoy KN: Short bowel syndrome: a nutritional and medical approach. CMAJ 2002;166:1297–1302.
8.
Sala D, Chomto S, Hill S: Long-term outcomes of short bowel syndrome requiring long-term/home intravenous nutrition compared in children with gastroschisis and those with volvulus. Transplant Proc 2010;42:5–8.
9.
Garne E, Loane M, Dolk H, EUROCAT Working Group: Gastrointestinal malformations: impact of prenatal diagnosis on gestational age at birth. Paediatr Perinat Epidemiol 2007;21:370–375.
10.
Japaraj RP, Hockey R, Chan FY: Gastroschisis: can prenatal sonography predict neonatal outcome? Ultrasound Obstet Gynecol 2003;21:329–333.
11.
Alsulyman OM, Monteiro H, Ouzounian JG, Barton L, Songster GS, Kovacs BW: Clinical significance of prenatal ultrasonographic intestinal dilatation in fetuses with gastroschisis. Am J Obstet Gynecol 1996;175;982–984.
12.
Badillo AT, Hedrick HL, Wilson RD, et al: Prenatal ultrasonographic gastrointestinal abnormalities, in fetuses with gastroschisis do not correlate with postnatal outcomes. J Pediatr Surg 2008;43:647–653.
13.
Nick AM, Bruner JP, Moses R, Yang EY, Scott TA. Second-trimester intra-abdominal bowel dilation in fetuses with gastroschisis predicts neonatal bowel atresia. Ultrasound Obstet Gynecol 2006;28:821–825.
14.
Maramreddy H, Fisher J, Slim M, Lagamma EF, Parvez B: Delivery of gastroschisis patients before 37 weeks of gestation is associated with increased morbidities. J Pediatr Surg 2009;44:1360–1366.
15.
Long AM, Court J, Morabiro A, Gilham JC: Antenatal diagnosis of bowel dilation in gastroschisis is predictive of poor postnatal outcome. J Pediatr Surg 2011;46:1070–1075.
16.
Guibourdenche J, Berrebi D, Vuillard E, de Lagausie P, Aigrain Y, Oury JF, Luton D: Biochemical investigations for bowel inflammation in gastroschisis. Pediatr Res 2006;60:565–568.
17.
Burc L, Volumenie JL, de Lagausie P, Guibourdenche J, Oury JF, Vuillard E, Sibony O, Blot P, Saizou C, Luton D: Amniotic fluid inflammatory proteins and digestive compounds profile in fetuses with gastroschisis undergoing amnioexchange. BJOG 2004;111:292–297.
18.
Langer J, Longaker MT, Crombleholme TM, Bond SJ, Finkbeiner WE, Rudolph CA, Verrier ED, Harrison M: Etiology of intestinal damage in gastroschisis. I: effects of amniotic fluid exposure and bowel constriction in a fetal lamb model. J Pediatr Surg 1989;24:992–997.
19.
Moir C, Ramsey PS, Ogburn PL, Johnson RV, Ramin KD: A prospective trial of elective preterm delivery for fetal gastroschisis. Am J Perinatol 2004:21:289–294.
20.
Huang J, Kurkchubasche AG, Carr SR, Wesselhoeft CW Jr, Tracy TF Jr, Luks FL: Benefits of term delivery in infants with antenatally diagnosed gastroschisis. Obstet Gynecol 1999;94:112–116.
21.
Santiago-Munoz, McIntire DD, Barber RG, Megison SM, Twickler DM, Dashe JS: Outcomes of pregnancies with fetal gastroschisis. Obstet Gynecol 2007;110:663–668.
22.
David AL, Tan A, Curry J: Gastroschisis: sonographic diagnosis, associations, management and outcome. Prenat Diagn 2008;28:633–644.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.